Oral Cavity Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Oral Cavity Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN) [Phase 2]
A Phase 2 trial assesses neoadjuvant chemotherapy combined with a PD-1 inhibitor for head and neck squamous cell carcinoma with the goal of …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation [NA]
A clinical trial update describes remote audiometry being studied to monitor treatment-related hearing loss in patients with head and neck s…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab given alone versus the standard chemotherapy with radiation after surgery for recurrent head…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer [Phase 1]
A Phase 1 clinical trial is evaluating the addition of the AKT inhibitor ipatasertib to standard chemotherapy and radiation for locally adva…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating cemiplimab plus CDX-1140 given before surgery to determine if the combination improves outcomes versus cemiplimab a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Artificial Intelligence for the Diagnosis of Oral Lesions
This clinical trial investigates using artificial intelligence to diagnose oral lesions and is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck [Phase 2]
A Phase 2 clinical trial is exploring adding ipatasertib to pembrolizumab in patients with recurrent or metastatic head and neck squamous ce…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating nisIN (nisin) for oral cavity squamous cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer [Phase 2, Phase 3]
NRG Oncology reports an ongoing Phase 2/3 trial comparing sentinel lymph node biopsy with standard neck dissection for early-stage oral cavi…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients [Phase 2]
Phase 2 trial evaluating first-line weekly chemotherapy combined with immunotherapy for metastatic head and neck squamous cell carcinoma; th…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC) [Phase 2]
Phase 2 trial exploring neoadjuvant XL-092 (zanzalintinib) with pembrolizumab (Keytruda) for surgically resectable, HPV-negative oral cavity…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel
Clinical trial update notes ongoing recruitment for an immune biomarker study in cisplatin-ineligible patients receiving chemoradiotherapy w…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 3]
Phase 3 trial evaluating combining radiation therapy with immunotherapy for metastatic and stage IV squamous cell carcinomas of the head and…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC). [Phase 2]
Phase 2 trial investigating neoadjuvant and adjuvant tiragolumab plus atezolizumab in newly diagnosed PD-L1 CPS-positive resectable stage 3-…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating cemiplimab in combination with low-dose paclitaxel and carboplatin f…
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Lattice-Based Radiotherapy and Chemo-Immunotherapy for Oral Cavity Squamous Cell Carcinoma [Phase 1]
A Phase 1 trial evaluating lattice-based radiotherapy combined with chemo-immunotherapy for oral cavity squamous cell carcinoma; the study i…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity Squamous Cell Carcinoma (OCSCC). [Phase 2]
Phase 2 clinical trial evaluating cemiplimab and cetuximab as prior salvage therapy before surgery for locally recurrent oral cavity squamou…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer [Phase 2]
A Phase 2 clinical trial evaluating compartmentalized postoperative radiotherapy in head and neck cancer, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial [Phase 2]
A Phase 2 clinical trial at the University of Michigan Rogel Cancer Center is evaluating personalized neck radiation therapy guided by senti…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck [Phase 2]
This is a Phase 2 clinical trial update examining nivolumab in combination with BMS986205 for stage II-IV squamous cell cancers of the head …
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study of durvalumab with or without tremelimumab in resectable locally advanced oral cavity squamous c…
-
CLINICAL_TRIALS research · 2024-05-17Clinical Trial Update: Neoadjuvant DaRT for Locally Advanced Oral Cavity SCC [NA]
A clinical trial update for neoadjuvant Diffusing Alpha-emitters Radiation Therapy (DaRT) in locally advanced oral cavity squamous cell carc…
-
CLINICAL_TRIALS research · 2016-09-22Clinical Trial Update: A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck [Phase 1]
A Phase 1 dose-escalation study of GC4419 in combination with chemoradiation for head and neck squamous cell carcinomas, including cancers o…